Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

Structure Therapeutics Inc. (NASDAQ: GPCR) is one of the best small cap stocks with biggest upside potential. On August 7, ...

It is vital that clinical trials for patients with cancer shift to a more representative approach to accurately reflect ...

The vaccine would train the immune system to fight cancer-causing mutations, according to new research from UCLA Health.

D Molecular Therapeutics advances 4D-150 for wet AMD and DME, revealing promising trial results and regulatory progress for ...

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight ...

It is important to expand clinical trial access for patients with kidney cancer in order to ensure a representative study population.

A Phase 1 human clinical trial to treat chronic spinal cord injury, the first of its kind in the world, has commenced to test ...

Diagnostics' progress on their PCR platform, with key trials in 2025 and commercialization plans by 2026, targeting U.S. and global markets.

Why is life so hard all the time? It seems that one problem pops up and then another. It never seems to end. – Frustrated ...

Rockefeller scientists engineered an enhanced CD40 agonist antibody to fight cancer that has improved efficacy and is administered in a way that limits serious side effects. In recent clinical trial ...